Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	tRNA (guanine) methyltransferase activity	TRMT1L TRMT5 TARBP1	6.77e-06	12	64	3	GO:0016423
GeneOntologyMolecularFunction	high-affinity IgG receptor activity	FCGR1A FCGR1BP	1.01e-05	2	64	2	GO:0019771
GeneOntologyMolecularFunction	leukotriene receptor binding	FCGR1A FCGR1BP	1.01e-05	2	64	2	GO:0031774
GeneOntologyMolecularFunction	2'-5'-oligoadenylate synthetase activity	OAS1 OAS3	1.01e-04	5	64	2	GO:0001730
GeneOntologyMolecularFunction	adenylyltransferase activity	PAPOLB OAS1 OAS3	1.32e-04	31	64	3	GO:0070566
GeneOntologyMolecularFunction	tRNA methyltransferase activity	TRMT1L TRMT5 TARBP1	1.75e-04	34	64	3	GO:0008175
GeneOntologyMolecularFunction	IgG receptor activity	FCGR1A FCGR1BP	2.10e-04	7	64	2	GO:0019770
GeneOntologyMolecularFunction	IgG binding	FCGR1A FCGR1BP	5.46e-04	11	64	2	GO:0019864
GeneOntologyMolecularFunction	immunoglobulin receptor activity	FCGR1A FCGR1BP	8.98e-04	14	64	2	GO:0019763
GeneOntologyMolecularFunction	RNA methyltransferase activity	TRMT1L TRMT5 TARBP1	1.30e-03	67	64	3	GO:0008173
GeneOntologyBiologicalProcess	acute inflammatory response	SCN11A SERPINA1 FCGR1A FCGR1BP PIK3CG CXCR2	4.91e-06	143	63	6	GO:0002526
GeneOntologyBiologicalProcess	negative regulation of IP-10 production	OAS1 OAS3	5.49e-05	4	63	2	GO:0071659
GeneOntologyBiologicalProcess	regulation of IP-10 production	OAS1 OAS3	9.13e-05	5	63	2	GO:0071658
GeneOntologyBiologicalProcess	IP-10 production	OAS1 OAS3	9.13e-05	5	63	2	GO:0071612
GeneOntologyBiologicalProcess	type III hypersensitivity	FCGR1A FCGR1BP	9.13e-05	5	63	2	GO:0001802
GeneOntologyBiologicalProcess	regulation of type III hypersensitivity	FCGR1A FCGR1BP	9.13e-05	5	63	2	GO:0001803
GeneOntologyBiologicalProcess	positive regulation of type III hypersensitivity	FCGR1A FCGR1BP	9.13e-05	5	63	2	GO:0001805
GeneOntologyBiologicalProcess	RNA methylation	TRMT1L TRMT5 TARBP1 LARP7	1.16e-04	82	63	4	GO:0001510
GeneOntologyBiologicalProcess	negative regulation of chemokine (C-X-C motif) ligand 2 production	OAS1 OAS3	1.37e-04	6	63	2	GO:2000342
GeneOntologyBiologicalProcess	tRNA methylation	TRMT1L TRMT5 TARBP1	2.66e-04	41	63	3	GO:0030488
GeneOntologyBiologicalProcess	positive regulation of acute inflammatory response	FCGR1A FCGR1BP PIK3CG	2.86e-04	42	63	3	GO:0002675
GeneOntologyBiologicalProcess	acute inflammatory response to antigenic stimulus	FCGR1A FCGR1BP CXCR2	2.86e-04	42	63	3	GO:0002438
GeneOntologyBiologicalProcess	positive regulation of interferon-beta production	TOMM70 OAS1 OAS3	4.00e-04	47	63	3	GO:0032728
GeneOntologyBiologicalProcess	positive regulation of type IIa hypersensitivity	FCGR1A FCGR1BP	4.07e-04	10	63	2	GO:0001798
GeneOntologyBiologicalProcess	negative regulation of chromatin binding	BTAF1 LARP7	4.07e-04	10	63	2	GO:0035562
GeneOntologyBiologicalProcess	regulation of ribonuclease activity	OAS1 OAS3	4.07e-04	10	63	2	GO:0060700
GeneOntologyBiologicalProcess	positive regulation of type II hypersensitivity	FCGR1A FCGR1BP	4.07e-04	10	63	2	GO:0002894
GeneOntologyBiologicalProcess	regulation of type IIa hypersensitivity	FCGR1A FCGR1BP	4.96e-04	11	63	2	GO:0001796
GeneOntologyBiologicalProcess	regulation of type II hypersensitivity	FCGR1A FCGR1BP	4.96e-04	11	63	2	GO:0002892
MousePheno	decreased susceptibility to induced arthritis	FCGR1A FCGR1BP PIK3CG CXCR2	5.30e-05	63	46	4	MP:0003436
MousePheno	decreased susceptibility to induced joint inflammation	FCGR1A FCGR1BP PIK3CG CXCR2	5.30e-05	63	46	4	MP:0003079
MousePheno	decreased susceptibility to autoimmune hemolytic anemia	FCGR1A FCGR1BP	1.05e-04	5	46	2	MP:0004828
Domain	NTP_transf_2	PAPOLB OAS1 OAS3	5.92e-06	11	63	3	PF01909
Domain	Polymerase_NTP_transf_dom	PAPOLB OAS1 OAS3	5.92e-06	11	63	3	IPR002934
Domain	OAS1_C	OAS1 OAS3	6.69e-05	4	63	2	PF10421
Domain	-	OAS1 OAS3	6.69e-05	4	63	2	1.10.1410.20
Domain	25A_SYNTH_1	OAS1 OAS3	6.69e-05	4	63	2	PS00832
Domain	25A_SYNTH_2	OAS1 OAS3	6.69e-05	4	63	2	PS00833
Domain	2-5-oligoadenylate_synth_CS	OAS1 OAS3	6.69e-05	4	63	2	IPR006117
Domain	25A_SYNTH_3	OAS1 OAS3	6.69e-05	4	63	2	PS50152
Domain	2-5-oligoAdlate_synth_1_dom2/C	OAS1 OAS3	6.69e-05	4	63	2	IPR018952
Domain	2-5A_synthase	OAS1 OAS3	6.69e-05	4	63	2	IPR026774
Domain	TIF_beta_prop-like	DCAF13 EIF3B	1.11e-04	5	63	2	IPR013979
Domain	eIF2A	DCAF13 EIF3B	1.11e-04	5	63	2	PF08662
Domain	2-5-oligoadenylate_synth_N	OAS1 OAS3	1.11e-04	5	63	2	IPR006116
Domain	Growth_fac_rcpt_	ELAPOR2 ERBB2 FRAS1 EYS ELAPOR1	1.81e-04	156	63	5	IPR009030
Domain	Man6P_isomerase_rcpt-bd_dom	ELAPOR2 ELAPOR1	3.09e-04	8	63	2	IPR009011
Domain	Furin_repeat	ERBB2 FRAS1	1.65e-03	18	63	2	IPR006212
Domain	FU	ERBB2 FRAS1	1.65e-03	18	63	2	SM00261
Domain	Ephrin_rec_like	ELAPOR2 ELAPOR1	3.20e-03	25	63	2	SM01411
Domain	Tyr-kin_ephrin_A/B_rcpt-like	ELAPOR2 ELAPOR1	3.20e-03	25	63	2	IPR011641
Domain	L_dom-like	ERBB2 LRRC34 LRRC75B FBXL13 OMG	4.96e-03	328	63	5	IPR032675
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	IBTK DCAF13 UPF2 MYO5A RRP9 BYSL SCAF11 TRMT1L UBE3C XRCC1 LARP7	1.53e-07	759	65	11	35915203
Pubmed	A protein interaction landscape of breast cancer.	TOMM70 ERBB2 DCAF13 MYO5A RRP9 SVIL SCAF11 TRMT1L UBE3C LARP7	2.74e-07	634	65	10	34591612
Pubmed	Single Nucleotide Polymorphisms of the High Affinity IgG Receptor FcγRI Reduce Immune Complex Binding and Downstream Effector Functions.	FCGR1A FCGR1BP	3.44e-06	2	65	2	28814603
Pubmed	Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan.	FCGR1A FCGR1BP	3.44e-06	2	65	2	37733444
Pubmed	Modulating IgG effector function by Fc glycan engineering.	FCGR1A FCGR1BP	3.44e-06	2	65	2	28289219
Pubmed	Amelioration of Lupus Serum-Induced Skin Inflammation in CD64-Deficient Mice.	FCGR1A FCGR1BP	3.44e-06	2	65	2	35273604
Pubmed	IgG3-mediated enhancement of the antibody response is normal in Fc gammaRI-deficient mice.	FCGR1A FCGR1BP	3.44e-06	2	65	2	16305642
Pubmed	Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1.	FCGR1A FCGR1BP	3.44e-06	2	65	2	9257847
Pubmed	Fcγ receptor I alpha chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1.	FCGR1A FCGR1BP	3.44e-06	2	65	2	21124939
Pubmed	Macrophages eliminate circulating tumor cells after monoclonal antibody therapy.	FCGR1A FCGR1BP	3.44e-06	2	65	2	24430180
Pubmed	Length dependent activation of OAS proteins by dsRNA.	OAS1 OAS3	3.44e-06	2	65	2	31629990
Pubmed	Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity.	FCGR1A FCGR1BP	3.44e-06	2	65	2	38885133
Pubmed	Novel Fc gamma receptor I family gene products in human mononuclear cells.	FCGR1A FCGR1BP	3.44e-06	2	65	2	1430234
Pubmed	The FcRgamma chain is not essential for induction of experimental allergic encephalomyelitis (EAE) or anti-myelin antibody-mediated exacerbation of EAE.	FCGR1A FCGR1BP	3.44e-06	2	65	2	15835266
Pubmed	Extracellular mutations of non-obese diabetic mouse FcgammaRI modify surface expression and ligand binding.	FCGR1A FCGR1BP	3.44e-06	2	65	2	8663283
Pubmed	The interaction of N-glycans in Fcγ receptor I α-chain with Escherichia coli K1 outer membrane protein A for entry into macrophages: experimental and computational analysis.	FCGR1A FCGR1BP	3.44e-06	2	65	2	25231998
Pubmed	Lentivirus-mediated knockdown of FcγRI (CD64) attenuated lupus nephritis via inhibition of NF-κB regulating NLRP3 inflammasome activation in MRL/lpr mice.	FCGR1A FCGR1BP	3.44e-06	2	65	2	30190171
Pubmed	The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma.	GALNT3 OAS1	3.44e-06	2	65	2	37919050
Pubmed	Molecular cloning and expression of the mouse high affinity Fc receptor for IgG.	FCGR1A FCGR1BP	3.44e-06	2	65	2	2136886
Pubmed	Gene organization of the human high affinity receptor for IgG, Fc gamma RI (CD64). Characterization and evidence for a second gene.	FCGR1A FCGR1BP	3.44e-06	2	65	2	1830050
Pubmed	FcRγ deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathway.	FCGR1A FCGR1BP	3.44e-06	2	65	2	30552619
Pubmed	Sensory Neuron Expressed FcγRI Mediates Postinflammatory Arthritis Pain in Female Mice.	FCGR1A FCGR1BP	3.44e-06	2	65	2	35833115
Pubmed	Differential gene expression modulated by the cytoplasmic domain of Fc gamma RIa (CD64) alpha-chain.	FCGR1A FCGR1BP	3.44e-06	2	65	2	15528358
Pubmed	Functional characteristics of the high affinity IgG receptor, FcγRI.	FCGR1A FCGR1BP	3.44e-06	2	65	2	21325219
Pubmed	Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis.	FCGR1A FCGR1BP	3.44e-06	2	65	2	14991835
Pubmed	Definition of interferon gamma-response elements in a novel human Fc gamma receptor gene (Fc gamma RIb) and characterization of the gene structure.	FCGR1A FCGR1BP	3.44e-06	2	65	2	1402657
Pubmed	FcR gamma-chain is essential for both surface expression and function of human Fc gamma RI (CD64) in vivo.	FCGR1A FCGR1BP	3.44e-06	2	65	2	8611682
Pubmed	Direct targeting of genetically modified tumour cells to Fc gammaRI triggers potent tumour cytotoxicity.	FCGR1A FCGR1BP	3.44e-06	2	65	2	16409296
Pubmed	Mouse FcgammaRI: identification and functional characterization of five new alleles.	FCGR1A FCGR1BP	3.44e-06	2	65	2	10752630
Pubmed	Fcγ Receptor Type I (CD64)-Mediated Impairment of the Capacity of Dendritic Cells to Activate Specific CD8 T Cells by IgG-opsonized Friend Virus.	FCGR1A FCGR1BP	3.44e-06	2	65	2	30744065
Pubmed	Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata.	FCGR1A FCGR1BP	3.44e-06	2	65	2	17124586
Pubmed	Neuronal FcγRI mediates acute and chronic joint pain.	FCGR1A FCGR1BP	3.44e-06	2	65	2	31211699
Pubmed	Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice.	FCGR1A FCGR1BP	3.44e-06	2	65	2	8480181
Pubmed	Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.	FCGR1A FCGR1BP	3.44e-06	2	65	2	29576375
Pubmed	High Anti-Dengue Virus Activity of the OAS Gene Family Is Associated With Increased Severity of Dengue.	OAS1 OAS3	3.44e-06	2	65	2	26063222
Pubmed	OAS1 and OAS3 negatively regulate the expression of chemokines and interferon-responsive genes in human macrophages.	OAS1 OAS3	3.44e-06	2	65	2	30078389
Pubmed	Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration.	FCGR1A FCGR1BP	3.44e-06	2	65	2	18245810
Pubmed	Reconstitution of allogeneic hemopoietic stem cells: the essential role of FcR gamma and the TCR beta-chain-FCp33 complex.	FCGR1A FCGR1BP	3.44e-06	2	65	2	16849450
Pubmed	The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation.	OAS1 OAS3	3.44e-06	2	65	2	17408844
Pubmed	Biochemical characterization of murine Fc gamma RI.	FCGR1A FCGR1BP	3.44e-06	2	65	2	8478020
Pubmed	FcγR-binding affinity of monoclonal murine IgG1s carrying different N-linked Fc oligosaccharides.	FCGR1A FCGR1BP	3.44e-06	2	65	2	31554601
Pubmed	CD64 plays a key role in diabetic wound healing.	FCGR1A FCGR1BP	3.44e-06	2	65	2	38524127
Pubmed	Developmentally ordered appearance of a functional Fc gamma receptor on TCR V gamma 3 thymocytes. Evidence for stimulation-induced expression.	FCGR1A FCGR1BP	3.44e-06	2	65	2	8077658
Pubmed	The involvement of FcR mechanisms in antibody-mediated rejection.	FCGR1A FCGR1BP	3.44e-06	2	65	2	18049118
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	IBTK UPF2 FBXO42 ELAPOR1 TRMT5	1.03e-05	153	65	5	10718198
Pubmed	The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.	OAS1 OAS3	1.03e-05	3	65	2	25275129
Pubmed	Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria.	FCGR1A FCGR1BP	1.03e-05	3	65	2	16841095
Pubmed	Nephrotoxic nephritis is mediated by Fcgamma receptors on circulating leukocytes and not intrinsic renal cells.	FCGR1A FCGR1BP	1.03e-05	3	65	2	12427132
Pubmed	MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I.	FCGR1A FCGR1BP	1.03e-05	3	65	2	22287715
Pubmed	Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice.	FCGR1A FCGR1BP	1.03e-05	3	65	2	23898046
Pubmed	The ribonuclease L-dependent antiviral roles of human 2',5'-oligoadenylate synthetase family members against hepatitis C virus.	OAS1 OAS3	1.03e-05	3	65	2	23196181
Pubmed	Serine phosphorylation of FcγRI cytoplasmic domain directs lipid raft localization and interaction with protein 4.1G.	FCGR1A FCGR1BP	1.03e-05	3	65	2	22003208
Pubmed	Association of Oligoadenylate Synthetase Gene Cluster and DC-SIGN (CD209) Gene Polymorphisms with Clinical Symptoms in Chikungunya Virus Infection.	OAS1 OAS3	1.03e-05	3	65	2	26398832
Pubmed	The human 2',5'-oligoadenylate synthetase locus is composed of three distinct genes clustered on chromosome 12q24.2 encoding the 100-, 69-, and 40-kDa forms.	OAS1 OAS3	1.03e-05	3	65	2	9790745
Pubmed	Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?	OAS1 OAS3	1.03e-05	3	65	2	16014697
Pubmed	Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.	ERBB2 PIK3CG	1.03e-05	3	65	2	18725974
Pubmed	Unique monoclonal antibodies define expression of Fc gamma RI on macrophages and mast cell lines and demonstrate heterogeneity among subcutaneous and other dendritic cells.	FCGR1A FCGR1BP	1.03e-05	3	65	2	12594281
Pubmed	Development of proteoglycan-induced arthritis is critically dependent on Fcgamma receptor type III expression.	FCGR1A FCGR1BP	1.03e-05	3	65	2	15880819
Pubmed	OAS1, OAS2 and OAS3 restrict intracellular M. tb replication and enhance cytokine secretion.	OAS1 OAS3	1.03e-05	3	65	2	30822544
Pubmed	A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies.	FCGR1A FCGR1BP	1.03e-05	3	65	2	28924242
Pubmed	Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.	FCGR1A FCGR1BP	1.03e-05	3	65	2	9892619
Pubmed	Adaptively introgressed Neandertal haplotype at the OAS locus functionally impacts innate immune responses in humans.	OAS1 OAS3	1.03e-05	3	65	2	27899133
Pubmed	Residual LCMV antigen in transiently CD4+ T cell-depleted mice induces high levels of virus-specific antibodies but only limited B-cell memory.	FCGR1A FCGR1BP	1.03e-05	3	65	2	30636035
Pubmed	DCAF13 promotes ovarian cancer progression by activating FRAS1-mediated FAK signaling pathway.	FRAS1 DCAF13	1.03e-05	3	65	2	39367995
Pubmed	Identification of 69-kd and 100-kd forms of 2-5A synthetase in interferon-treated human cells by specific monoclonal antibodies.	OAS1 OAS3	1.03e-05	3	65	2	2440675
Pubmed	Cutting Edge: Drebrin-Regulated Actin Dynamics Regulate IgE-Dependent Mast Cell Activation and Allergic Responses.	FCGR1A FCGR1BP	1.03e-05	3	65	2	26056254
Pubmed	The essential role of complement in antibody-mediated resistance to Salmonella.	FCGR1A FCGR1BP	1.03e-05	3	65	2	30179254
Pubmed	The three genes of the human FCGR1 gene family encoding Fc gamma RI flank the centromere of chromosome 1 at 1p12 and 1q21.	FCGR1A FCGR1BP	1.03e-05	3	65	2	8697799
Pubmed	Transcriptional and post-transcriptional regulation of IκB-ζ upon engagement of the BCR, TLRs and FcγR.	FCGR1A FCGR1BP	1.03e-05	3	65	2	23728777
Pubmed	FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation.	FCGR1A FCGR1BP	1.03e-05	3	65	2	22493081
Pubmed	FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways.	FCGR1A FCGR1BP	1.03e-05	3	65	2	16543474
Pubmed	OAS1, OAS2, and OAS3 Contribute to Epidermal Keratinocyte Proliferation by Regulating Cell Cycle and Augmenting IFN-1‒Induced Jak1‒Signal Transducer and Activator of Transcription 1 Phosphorylation in Psoriasis.	OAS1 OAS3	1.03e-05	3	65	2	35305973
Pubmed	Escherichia coli K1 induces pterin production for enhanced expression of Fcγ receptor I to invade RAW 264.7 macrophages.	FCGR1A FCGR1BP	1.03e-05	3	65	2	24161960
Pubmed	Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.	OAS1 OAS3	1.03e-05	3	65	2	33138195
Pubmed	Both Fcgamma receptor I and Fcgamma receptor III mediate disease in accelerated nephrotoxic nephritis.	FCGR1A FCGR1BP	1.03e-05	3	65	2	12707052
Pubmed	FcgammaRI ligation leads to a complex with BLT1 in lipid rafts that enhances rat lung macrophage antimicrobial functions.	FCGR1A FCGR1BP	1.03e-05	3	65	2	19657115
Pubmed	Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection.	FCGR1A FCGR1BP	1.03e-05	3	65	2	33032297
Pubmed	Localization of FCGR1 encoding Fcgamma receptor class I in primates: molecular evidence for two pericentric inversions during the evolution of human chromosome 1.	FCGR1A FCGR1BP	1.03e-05	3	65	2	9763663
Pubmed	C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody Complexes.	FCGR1A FCGR1BP	1.03e-05	3	65	2	28432146
Pubmed	Polymorphisms in the oligoadenylate synthetase gene cluster and its association with clinical outcomes of dengue virus infection.	OAS1 OAS3	1.03e-05	3	65	2	23337612
Pubmed	Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity.	FCGR1A FCGR1BP	1.03e-05	3	65	2	30297432
Pubmed	FcgammaRI up-regulation induced by local adenoviral-mediated interferon-gamma production aggravates chondrocyte death during immune complex-mediated arthritis.	FCGR1A FCGR1BP	1.03e-05	3	65	2	12875993
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	TOMM70 GALNT3 MYO5A RRP9 ELAPOR1 BYSL SCAF11 EIF3B TRMT1L XRCC1 STAG2 LARP7	1.88e-05	1497	65	12	31527615
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	DCAF13 UPF2 MYO5A RRP9 SVIL BYSL OAS3 SCAF11 EIF3B PSMD13 TRMT1L	1.96e-05	1257	65	11	36526897
Pubmed	Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity.	FCGR1A FCGR1BP	2.06e-05	4	65	2	9551950
Pubmed	Gene structure of the murine 2'-5'-oligoadenylate synthetase family.	OAS1 OAS3	2.06e-05	4	65	2	12222967
Pubmed	C-reactive protein-mediated suppression of nephrotoxic nephritis: role of macrophages, complement, and Fcgamma receptors.	FCGR1A FCGR1BP	2.06e-05	4	65	2	17182593
Pubmed	Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction.	FCGR1A FCGR1BP	2.06e-05	4	65	2	16517729
Pubmed	Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal.	FCGR1A FCGR1BP	2.06e-05	4	65	2	29511065
Pubmed	Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.	FCGR1A FCGR1BP	2.06e-05	4	65	2	21169548
Pubmed	Evidence for Cd101 but not Fcgr1 as candidate for type 1 diabetes locus, Idd10.	FCGR1A FCGR1BP	2.06e-05	4	65	2	15850792
Pubmed	Human immunoglobulin G hinge regulates agonistic anti-CD40 immunostimulatory and antitumour activities through biophysical flexibility.	FCGR1A FCGR1BP	2.06e-05	4	65	2	31562320
Pubmed	Fc receptor regulation of protective immunity against Chlamydia trachomatis.	FCGR1A FCGR1BP	2.06e-05	4	65	2	11872097
Pubmed	Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRgamma-deficient mice.	FCGR1A FCGR1BP	2.06e-05	4	65	2	10760808
Pubmed	Adenovirus-mediated human immunodeficiency virus-1 Nef expression in human monocytes/macrophages and effect of Nef on downmodulation of Fcgamma receptors and expression of monokines.	FCGR1A FCGR1BP	2.06e-05	4	65	2	9490697
Pubmed	Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo.	FCGR1A FCGR1BP	2.06e-05	4	65	2	16455953
Pubmed	Three genes for the human high affinity Fc receptor for IgG (Fc gamma RI) encode four distinct transcription products.	FCGR1A FCGR1BP	2.06e-05	4	65	2	1379234
Pubmed	A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation.	FCGR1A FCGR1BP	2.06e-05	4	65	2	12517949
Pubmed	The high-affinity IgG receptor, FcgammaRI, plays a central role in antibody therapy of experimental melanoma.	FCGR1A FCGR1BP	2.06e-05	4	65	2	16452176
Pubmed	The mouse Fc receptor for IgG (Ly-17): molecular cloning and specificity.	FCGR1A FCGR1BP	2.06e-05	4	65	2	2957319
Cytoband	12q24.2	OAS1 OAS3	2.34e-04	16	65	2	12q24.2
Cytoband	Ensembl 112 genes in cytogenetic band chr7p22	GET4 PAPOLB EIF3B	9.30e-04	134	65	3	chr7p22
Cytoband	8q22.3	SLC25A32 DCAF13	1.08e-03	34	65	2	8q22.3
Cytoband	7p22.3	GET4 EIF3B	1.08e-03	34	65	2	7p22.3
Cytoband	Ensembl 112 genes in cytogenetic band chr2p15	SANBR WDPCP	1.80e-03	44	65	2	chr2p15
Cytoband	Ensembl 112 genes in cytogenetic band chr10q23	SHLD2 BTAF1 SH2D4B	2.72e-03	195	65	3	chr10q23
Cytoband	Ensembl 112 genes in cytogenetic band chr7q22	FBXL13 PIK3CG FAM200A	3.76e-03	219	65	3	chr7q22
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	CD1C ERBB2 FCGR1A CXCR2	9.14e-03	394	38	4	471
Coexpression	GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	FCGR1A GVINP1 MARCHF6 NFXL1 OAS3	4.89e-05	160	65	5	M8664
Coexpression	PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_TOP_30_DEG_UP	SERPINA1 FCGR1A FCGR1BP	5.08e-05	29	65	3	M40976
Coexpression	PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGED_POST_VACCINATION_VS_UNCHALLENGED_72HR_TOP_30_DEG_UP	SERPINA1 FCGR1A FCGR1BP	5.63e-05	30	65	3	M40975
Coexpression	SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_7DY_DN	SERPINA1 OAS1 OAS3	7.53e-05	33	65	3	M41194
Coexpression	GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP	ZDHHC2 GALNT3 GVINP1 MYO5A PIK3CG	8.11e-05	178	65	5	M6326
Coexpression	DESCARTES_FETAL_LUNG_MYELOID_CELLS	CD1C ATP8B4 FCGR1A FCGR1BP KCNMB1	8.11e-05	178	65	5	M40244
Coexpression	CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_UP	FCGR1A FCGR1BP	9.03e-05	6	65	2	M41151
Coexpression	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP	ZDHHC2 RRP9 SCAF11 XRCC1 WDPCP	1.08e-04	189	65	5	M9978
Coexpression	GSE45365_BCELL_VS_CD8_TCELL_UP	ZDHHC2 PHKA1 GCNT7 UPF2 WDPCP	1.10e-04	190	65	5	M9991
Coexpression	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	GET4 PAPOLB EIF3B	1.15e-04	38	65	3	M15884
Coexpression	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN	ZDHHC2 ATP8B4 FBXO42 SVIL STAG2	1.31e-04	197	65	5	M7921
Coexpression	NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_ATIV_UP	FCGR1A FCGR1BP OAS3	1.35e-04	40	65	3	M40897
Coexpression	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP	ATP8B4 FCGR1A NFXL1 OAS1 OAS3	1.40e-04	200	65	5	M6625
Coexpression	WEI_MYCN_TARGETS_WITH_E_BOX	SLC25A32 DCAF13 UPF2 MYO5A RRP9 HDAC8 BYSL EIF3B PSMD13	1.41e-04	792	65	9	M12113
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A FCGR1BP PIK3CG OAS1	3.21e-07	187	65	6	23be50d81f4404a609dea821e1a66d221c0e0615
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A FCGR1BP PIK3CG OAS1	3.63e-07	191	65	6	367d300da3925e0a329271b5f19483a37265a878
ToppCell	severe-Myeloid-Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SERPINA1 FCGR1A FCGR1BP OAS1 OAS3 CXCR2	4.35e-07	197	65	6	c8a90d82170cf20e14aebecddcf7cc0ca56cda87
ToppCell	control-Myeloid-Neutrophils_2\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SERPINA1 FCGR1A FCGR1BP OAS1 OAS3 CXCR2	4.35e-07	197	65	6	8819db1550bf14566c6d33d97f7f83419e867ace
ToppCell	severe-Myeloid-Neutrophils_2\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SERPINA1 FCGR1A FCGR1BP OAS1 OAS3 CXCR2	4.48e-07	198	65	6	636878836678a0715550fa09f2e3dac11c4d73fe
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ARMH2 GALNT3 B3GNT7 CXCR2	3.39e-06	70	65	4	986c7a1002a4ffd3a246495bedde2997ffdc2c9d
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ARMH2 GALNT3 B3GNT7 CXCR2	3.39e-06	70	65	4	c0330216305491d7d57cdbea0ae3cb8e9092c8e3
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE-P3\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ARMH2 GALNT3 B3GNT7 CXCR2	3.39e-06	70	65	4	86dde790fcdaec2095e2256463953077811145d2
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ARMH2 GALNT3 B3GNT7 CXCR2	3.39e-06	70	65	4	e604660b2efbc03e21806dcaecf7a72321673ae2
ToppCell	PBMC-Control-Myeloid-Neutrophil-Neutrophil-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GET4 FCGR1BP ELAPOR1 ACVR2B CXCR2	3.71e-06	160	65	5	70f3637dd0bcfcef421aa114f946fff0048f192e
ToppCell	cellseq2-Immune-Hematopoietic-Granulocytic-Neutrophil\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ARMH2 SERPINA1 FCGR1A FCGR1BP CXCR2	6.96e-06	182	65	5	1932d77491d6d46278f01fd70eb469ef1b356619
ToppCell	cellseq2-Immune-Hematopoietic-Granulocytic\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ARMH2 SERPINA1 FCGR1A FCGR1BP CXCR2	7.14e-06	183	65	5	cfbf8539104cef9ca830ad4f6bb278746f7078f7
ToppCell	cellseq2-Immune-Hematopoietic\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ARMH2 SERPINA1 FCGR1A FCGR1BP CXCR2	7.14e-06	183	65	5	324ec4374b552da7ce03809945b3a0798342d4ba
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175\|Adult / Lineage, Cell type, age group and donor	ATP8B4 FCGR1A FCGR1BP MYO5A GFRA2	7.53e-06	185	65	5	ab5704b96f1d368911308797d10c7c52766ab134
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A FCGR1BP PIK3CG	7.73e-06	186	65	5	6575ec6a626cdea169ffd185d47828dfaa29475d
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_dendritic_(11)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A PIK3CG OAS1	7.73e-06	186	65	5	fc6e591089c87a66653c8e552be9c0fe0c82ecd5
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SERPINA1 ATP8B4 FCGR1A FCGR1BP PIK3CG	7.73e-06	186	65	5	cb4ea1bc1427230070e9696baeda7de241c354b1
ToppCell	368C-Myeloid-Macrophage-FABP4+_Macrophage_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	SERPINA1 FCGR1A FCGR1BP OAS1 B3GNT7	7.73e-06	186	65	5	ddfadd43efeac3b3e6b7062590cc2b8f2f2db2ab
ToppCell	368C-Myeloid-Macrophage\|368C / Donor, Lineage, Cell class and subclass (all cells)	SERPINA1 FCGR1A FCGR1BP OAS1 B3GNT7	8.35e-06	189	65	5	e62355be0d136e2b7c739848022292e9c6af7392
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ATP8B4 FCGR1A FCGR1BP PIK3CG OAS1	8.57e-06	190	65	5	e5625feb21915d4545cfad2659745ef180efcb1f
ToppCell	(2)_Dendritic_Cells\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CD1C SERPINA1 ATP8B4 FCGR1A KCNMB1	8.57e-06	190	65	5	5163a5be95fb6c2609bfa3d69166af172f74e724
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A FCGR1BP PIK3CG	8.57e-06	190	65	5	5e0e4a48159ec05ba1b599752b769a7b4da08588
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A FCGR1BP PIK3CG	9.01e-06	192	65	5	7e7383093efaadceadd4d1f900c2d39cd690102e
ToppCell	PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A PIK3CG CXCR2	9.24e-06	193	65	5	c9e3fefa8d68d0e2b954f85ce37813185ff98d84
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A PIK3CG OAS1	9.24e-06	193	65	5	2684fa361baaa9dc7a18a39ed11c0759e78e4418
ToppCell	(2)_MNPs\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CD1C SERPINA1 FCGR1A FCGR1BP KCNMB1	9.48e-06	194	65	5	9cd64e325ec233da82c463b09262efe93d2a92ee
ToppCell	control-Myeloid-Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	FCGR1A FCGR1BP OAS1 OAS3 CXCR2	9.48e-06	194	65	5	267e213e8efe53aadfe553a2ca010a0e3b4b8939
ToppCell	PBMC-Mild-cDC_1\|Mild / Compartment, Disease Groups and Clusters	CD1C UPF2 OAS3 SCAF11 LARP7	9.72e-06	195	65	5	674355ca00314bde90ef7f6ddb83afe2d5323130
ToppCell	PCW_05-06-Hematologic_Myeloid\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A PIK3CG OAS1	9.96e-06	196	65	5	b2aee2f67da373a10b0c25e7797e30e3811543a8
ToppCell	COVID-19-Myeloid-MoAM1,_IL1R2\|COVID-19 / Condition, Lineage and Cell class	SERPINA1 FCGR1A FCGR1BP OAS1 OAS3	1.02e-05	197	65	5	4a9c61b37c938bb26929593007d713382ae1eb79
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SERPINA1 FCGR1A FCGR1BP OAS1 OAS3	1.02e-05	197	65	5	383d598ce3f8f5fc98bef3300e4cf7b6992aec9c
ToppCell	COVID-19_Moderate-Classical_Monocyte\|World / disease group, cell group and cell class	SERPINA1 FCGR1A FCGR1BP OAS1 OAS3	1.02e-05	197	65	5	16cf3939e700aef1e16159f0652ba2dfad287e7a
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SERPINA1 FCGR1A FCGR1BP OAS1 OAS3	1.02e-05	197	65	5	3cc4e56a77f96a43f9b5a24cf1b9524c927ef795
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A FCGR1BP PIK3CG	1.05e-05	198	65	5	1d242fbe4ae3628103f6b6f910a7641bb1b75266
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_2\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CD1C SERPINA1 ATP8B4 FCGR1A GFRA2	1.05e-05	198	65	5	115f564af8d7b89ac0331d3831faaef694043fd4
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Myeloid-Microglia\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	SERPINA1 ATP8B4 FCGR1A FCGR1BP OAS1	1.05e-05	198	65	5	c0d33629438504a1545e07f0e5af2e76f50fd55b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SERPINA1 FCGR1A OAS3 GFRA2 CXCR2	1.05e-05	198	65	5	e2038d9239e23d670d539f1c58475fd0de028e51
ToppCell	PCW_13-14-Hematologic_Myeloid\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CD1C SERPINA1 ATP8B4 FCGR1A PIK3CG	1.05e-05	198	65	5	d42fce8e547dc97f3cf144ab65483a1b11ace267
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Myeloid\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	SERPINA1 ATP8B4 FCGR1A FCGR1BP OAS1	1.05e-05	198	65	5	2b93995f66c7352acc25d6c71d025b847881dacd
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid-Microglia\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	SERPINA1 ATP8B4 FCGR1A FCGR1BP OAS1	1.07e-05	199	65	5	4ddfbcaa8054b69b3398d8c0d5fab8ae94805cb9
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	SERPINA1 ATP8B4 FCGR1A FCGR1BP OAS1	1.07e-05	199	65	5	3ba48a4715d5e9387650aa97e0c5d7f7897bf380
ToppCell	mild-CD163+_Monocytes_(Sample_ID1_d7)\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SERPINA1 FCGR1A FCGR1BP OAS1 OAS3	1.10e-05	200	65	5	99eb02f974ddc8d1882f4a5b34d4503d6ec0a5f5
ToppCell	mild-CD163+_Monocytes_(Sample_ID1_d7)\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SERPINA1 FCGR1A FCGR1BP OAS1 OAS3	1.10e-05	200	65	5	82126e25bfd8fba78dc1348fa5ad6a576289a139
ToppCell	severe-CD163+_Monocytes_(Sample_ID1_d7)\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SERPINA1 FCGR1A FCGR1BP OAS1 OAS3	1.10e-05	200	65	5	4943fe826d5fcc3dfeb8b99a7415848f3fecc994
ToppCell	COVID_non-vent\|World / Disease condition, Lineage, Cell class and subclass	SERPINA1 FCGR1A FCGR1BP OAS1 OAS3	1.10e-05	200	65	5	accef1050963dc91e189ac3d38228f15bf57e06e
ToppCell	Cerebellum-Macroglia-CSF_related\|Cerebellum / BrainAtlas - Mouse McCarroll V32	ARMH2 LRRC34 ATP8B4 FBXL13	4.82e-05	137	65	4	f004199b654143e9e766e5c5f56858089e98cf5f
ToppCell	Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)--\|Cerebellum / BrainAtlas - Mouse McCarroll V32	ARMH2 LRRC34 ATP8B4 FBXL13	4.82e-05	137	65	4	6a5599af9d0ee1be6cac17af09aa4cd50774c683
ToppCell	Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	ARMH2 LRRC34 ATP8B4 FBXL13	4.82e-05	137	65	4	01cbc9082e10ef51a1763a8b2d708eea0434490f
ToppCell	Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	ARMH2 LRRC34 ATP8B4 FBXL13	4.82e-05	137	65	4	a22730b6f78b66bb3c46155af37c34e554672dee
ToppCell	Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS\|Cerebellum / BrainAtlas - Mouse McCarroll V32	ARMH2 LRRC34 ATP8B4 FBXL13	4.82e-05	137	65	4	ce7c57dad201bd2164fc8b1172aca709f3f7def2
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCGR1A FCGR1BP B3GNT7 CXCR2	5.39e-05	141	65	4	2d2c468783730d81e3cacb0336027ba0ce1e5f4f
ToppCell	VE-CD8-antiviral_CD4\|VE / Condition, Cell_class and T cell subcluster	FBXL13 OAS1 OAS3 OMG	6.51e-05	148	65	4	f49f579650b57cc4c6c7a7fa726447740d3dc695
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B4 GVINP1 MYO5A OMG	6.68e-05	149	65	4	48fca6ae33d7722c024b43ce04f4dbce7b6b424b
ToppCell	Club-club-1\|World / Class top	LRRC75B FBXO42 SH2D4B	6.77e-05	54	65	3	48f80b20b1c4995a0f7084d31666781dce4009a9
ToppCell	E16.5-samps-Myeloid-Fetal_macrophage-Proliferative_Myeloid\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ATP8B4 FCGR1BP GVINP1 PIK3CG	7.22e-05	152	65	4	e427758a6e39052616a0d8ecec0c1299e81d1d3c
ToppCell	E16.5-samps-Myeloid-Fetal_macrophage\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ATP8B4 FCGR1BP GVINP1 PIK3CG	7.41e-05	153	65	4	e9567966fe4426176e2f2dc0be4832c769c9903a
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXL13 PIK3CG SVIL KCNMB1	7.41e-05	153	65	4	3b1b0cc8e9dd2b1484649789330713282ee44414
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CD1C OAS1 OAS3 GFRA2	8.39e-05	158	65	4	216b3f482daa2d0d7fcaf5a8559e3ccbdb8e110d
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD1C OAS1 OAS3 GFRA2	8.39e-05	158	65	4	9712bb8b1bacb8a38c99a22bc2babec5d5160e2a
ToppCell	E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated\|E18.5-samps / Age Group, Lineage, Cell class and subclass	ATP8B4 FCGR1BP GVINP1 PIK3CG	9.24e-05	162	65	4	60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed
ToppCell	E18.5-samps-Myeloid\|E18.5-samps / Age Group, Lineage, Cell class and subclass	ATP8B4 FCGR1BP GVINP1 PIK3CG	9.24e-05	162	65	4	18e4a807e25f754a69e9eaaddfde40f8de9b8512
ToppCell	E18.5-samps-Myeloid-Macrophage\|E18.5-samps / Age Group, Lineage, Cell class and subclass	ATP8B4 FCGR1BP GVINP1 PIK3CG	9.24e-05	162	65	4	0970e4eda60e3f015335e2726e6d565fb2f43372
ToppCell	COPD-Lymphoid-ILC_B\|Lymphoid / Disease state, Lineage and Cell class	ATP8B4 SVIL ELAPOR1 B3GNT7	1.02e-04	166	65	4	e2cad1db536d5ad5a34c337c19b5e7d1a2851552
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A OAS1	1.04e-04	167	65	4	0d187e40a5b96b595761f7aea1a0835462d8270f
ToppCell	normal_Lymph_Node-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	SERPINA1 FCGR1A FCGR1BP OAS3	1.04e-04	167	65	4	820472887f43b42ae7e44513ca3d5465fb4f71a7
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3\|TCGA-Stomach / Sample_Type by Project: Shred V9	CD1C ATP8B4 GVINP1 PIK3CG	1.04e-04	167	65	4	d2230c894ccf9dbba9196e079ae81f384d43da63
ToppCell	PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FCGR1BP MYO5A B3GNT7 UBE3C	1.06e-04	168	65	4	cc0dd43d5cda01e643d8e8d74ec7617d61890760
ToppCell	390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|390C / Donor, Lineage, Cell class and subclass (all cells)	FCGR1A FCGR1BP MYO5A GFRA2	1.09e-04	169	65	4	2c851b2703c7b8b656026f996f5fc027e4a79b36
ToppCell	facs-Lung-EPCAM-18m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBB2 ERI2 SH2D4B TARBP1	1.11e-04	170	65	4	12203d4410f38cc933d9f160b5fb76828df94119
ToppCell	facs-Lung-EPCAM-18m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBB2 ERI2 SH2D4B TARBP1	1.11e-04	170	65	4	f9decb3bf3bf6d4996b0ac27af768236e116aac5
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCGR1BP OAS1 OAS3 TARBP1	1.24e-04	175	65	4	97616bb5c127284aa9e67bc336dfcf29e137164b
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EYS ATP8B4 ELAPOR1 B3GNT7	1.33e-04	178	65	4	0b59e3d75b143bd7bf91a7800a49699c51e68c5a
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	FAM200A TRMT5 TARBP1 CXCR2	1.36e-04	179	65	4	10c7d371937d9d93c12c8d3465430ef9e0c2ec81
ToppCell	mild_COVID-19-NK_CD56bright\|mild_COVID-19 / disease group, cell group and cell class (v2)	ELAPOR2 FRAS1 ATP8B4 B3GNT7	1.39e-04	180	65	4	d8b418edd807a51c0b5f4018b8b478dcc65892a7
ToppCell	metastatic_Brain-Myeloid_cells-Pleural_Mac\|metastatic_Brain / Location, Cell class and cell subclass	CD1C SERPINA1 FCGR1A FCGR1BP	1.39e-04	180	65	4	7de1c8ab1152fa517c6b4830d93ff53a19fca3d7
ToppCell	normal_Lymph_Node-Myeloid_cells-Pleural_Mac\|normal_Lymph_Node / Location, Cell class and cell subclass	CD1C SERPINA1 FCGR1A FCGR1BP	1.42e-04	181	65	4	921e917f83105896ad8918dc134b871708024021
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LRRC75B KCNMB1 ACVR2B TRMT5	1.42e-04	181	65	4	274c0b768925cd5804483303f8c5ebd17a534c41
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SERPINA1 ATP8B4 FCGR1A FCGR1BP	1.42e-04	181	65	4	3457c1d431db4282be5a6243119e48960748ede7
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SERPINA1 FCGR1A FCGR1BP CXCR2	1.45e-04	182	65	4	f9c013075477e77a8373c73301a51e7e3f35369c
ToppCell	PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A PIK3CG	1.48e-04	183	65	4	aed12b743334f3813db0c70d4fe7df90e0673f54
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SERPINA1 FCGR1A FCGR1BP CXCR2	1.48e-04	183	65	4	340621a8e720bd98da335f90598096833681834c
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A PIK3CG	1.48e-04	183	65	4	24679153b654c148dbd572e9013c0a6e58718ada
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SERPINA1 FCGR1A FCGR1BP CXCR2	1.48e-04	183	65	4	75da8c05b6d636f434c5684e0166fed0de3547b4
ToppCell	Control-CD8+_T_activated\|Control / Disease group and Cell class	PIK3CG SANBR OAS1 OAS3	1.51e-04	184	65	4	b86cc48b744b3206880ec1373fe6068e14bf9680
ToppCell	PBMC-Mild-cDC_9\|Mild / Compartment, Disease Groups and Clusters	FCGR1BP OAS3 ACVR2B GFRA2	1.51e-04	184	65	4	2e0c9a2c40c892a2d435eafb31f1f838de9baf15
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZDHHC2 RRP9 ELAPOR1 CASP10	1.54e-04	185	65	4	7925519b855f76444a0b57382ce35d89457b0b14
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	FAM200A TRMT5 TARBP1 CXCR2	1.54e-04	185	65	4	daea170d827226dda6750bf1838ffd82f070c4d4
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SERPINA1 ATP8B4 FCGR1A FCGR1BP	1.57e-04	186	65	4	e41f14aee8cfbf76b8d0d4695a6170e2cd92aec8
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CD1C ATP8B4 FCGR1A FCGR1BP	1.57e-04	186	65	4	73185d48c874e18dd2e2eeea67c32d3182ea88a5
ToppCell	droplet-Liver-Npc-18m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELAPOR2 GVINP1 HDAC8 ACVR2B	1.57e-04	186	65	4	75258d88e23112fd1f0f7c71ef0366abb400d33e
ToppCell	Influenza-Influenza_Severe-Myeloid-Neutrophil\|Influenza_Severe / Disease, condition lineage and cell class	CDKL5 FBXL13 SVIL CXCR2	1.57e-04	186	65	4	1dfcec9196d4db76fba3abc74e85885b1fb98b87
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SERPINA1 ATP8B4 FCGR1A FCGR1BP	1.57e-04	186	65	4	b3633cd4e360c5b45060c50b4f606d483e03a89a
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SERPINA1 ATP8B4 FCGR1A FCGR1BP	1.57e-04	186	65	4	9dd31dc9af1704f35c74de726a6c27fa21e9a014
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	EYS GET4 B3GNT7 GFRA2	1.60e-04	187	65	4	f31d865ce2a21bdf64dbe29ee3e4505ab482604a
ToppCell	5'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-cDC2\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD1C ATP8B4 PIK3CG OAS1	1.64e-04	188	65	4	72a1ee136d77c77e44793a512f60b5f7815a073a
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic\|GI_large-bowel / Manually curated celltypes from each tissue	SERPINA1 FCGR1A KCNMB1 GFRA2	1.64e-04	188	65	4	d0045fdda757d191dabc7853f6a6e99c0e97d93d
ToppCell	LAM-Myeloid-DC\|LAM / Condition, Lineage and Cell class	CD1C ATP8B4 KCNMB1 GFRA2	1.64e-04	188	65	4	b4140110c2f7d25fd8a0d2749e33e02003ac4bf2
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ATP8B4 FCGR1A FCGR1BP PIK3CG	1.64e-04	188	65	4	8fc15c8b78fdd1a578e34325011bc5a87a8aab31
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes\|GI_large-bowel / Manually curated celltypes from each tissue	SERPINA1 FCGR1A KCNMB1 GFRA2	1.64e-04	188	65	4	0bcf04aa47738f43c1a87dae5dc487738ee86f8c
ToppCell	5'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD1C ATP8B4 PIK3CG OAS1	1.64e-04	188	65	4	ecbba19eebba21b986caa99de78ea4245fde3600
Disease	neutrophil elastase measurement	SERPINA1 ATP8B4	2.68e-05	4	63	2	EFO_0020605
Disease	response to platinum based chemotherapy, cytotoxicity measurement	FRAS1 EYS	4.47e-05	5	63	2	EFO_0004647, EFO_0006952
Disease	Gastric cancer	ERBB2 CASP10	2.44e-04	11	63	2	cv:C0024623
Disease	Neoplasm of stomach	ERBB2 CASP10	2.44e-04	11	63	2	cv:C0038356
Disease	GASTRIC CANCER	ERBB2 CASP10	2.44e-04	11	63	2	613659
Disease	pre-eclampsia (is_marker_for)	ERBB2 SERPINA1 ACVR2B	2.63e-04	58	63	3	DOID:10591 (is_marker_for)
Disease	Hereditary Diffuse Gastric Cancer	ERBB2 SERPINA1 RRP9 CASP10 XRCC1	4.10e-04	293	63	5	C1708349
Disease	Stomach Neoplasms	ERBB2 SERPINA1 RRP9 CASP10 XRCC1	4.36e-04	297	63	5	C0038356
Disease	Malignant neoplasm of stomach	ERBB2 SERPINA1 RRP9 CASP10 XRCC1	4.56e-04	300	63	5	C0024623
Disease	stomach cancer (is_implicated_in)	ERBB2 CASP10 XRCC1	4.98e-04	72	63	3	DOID:10534 (is_implicated_in)
Disease	urinary bladder cancer (is_implicated_in)	ERBB2 XRCC1 CXCR2	5.83e-04	76	63	3	DOID:11054 (is_implicated_in)
Disease	Benign neoplasm of stomach	ERBB2 CASP10	5.98e-04	17	63	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	ERBB2 CASP10	5.98e-04	17	63	2	C0496905
Disease	Carcinoma in situ of stomach	ERBB2 CASP10	5.98e-04	17	63	2	C0154060
Disease	serum gamma-glutamyl transferase measurement	SERPINA1 EYS LRRC75B GALNT3 FBXO42 SVIL OAS1 OMG	7.05e-04	914	63	8	EFO_0004532
Disease	Glioma	ERBB2 XRCC1 STAG2	8.65e-04	87	63	3	C0017638
Disease	Stomach Carcinoma	ERBB2 CASP10	9.18e-04	21	63	2	C0699791
Disease	nucleus accumbens volume change measurement, age at assessment	CCDC190 B3GNT7	1.01e-03	22	63	2	EFO_0008007, EFO_0021493
Disease	HIV Coinfection	SERPINA1 EIF3B PSMD13	1.41e-03	103	63	3	C4505456
Disease	HIV Infections	SERPINA1 EIF3B PSMD13	1.41e-03	103	63	3	C0019693
Disease	retinal degeneration (biomarker_via_orthology)	FCGR1A FCGR1BP	1.64e-03	28	63	2	DOID:8466 (biomarker_via_orthology)
Disease	respiratory failure, COVID-19	OAS1 OAS3	1.76e-03	29	63	2	EFO_0009686, MONDO_0100096

Protein segments in the cluster

Peptide	Gene	Start	Entry
KICLSQFCKWIHKIQ	ERI2	111	A8K979
LCYQDTILWKDIFHK	ERBB2	161	P04626
KLHWQKNGDYLCVKV	EIF3B	516	P55884
KIKILLLQSVACWCY	ARMH2	116	H3BNL8
FNIQHCKKLSSWVLL	SERPINA1	251	P01009
QKLKSYDTWINICLT	GVINP1	551	Q7Z2Y8
KTHYNSTSWIENLCK	ATP8B4	1161	Q8TF62
LENCLLGQYKLNWKH	FAM200A	191	Q8TCP9
QHVICVKWTSDSKYI	DCAF13	326	Q9NV06
LYQKSVWTQESKCHL	KCNMB1	41	Q16558
KYNGILHCLTTIWKL	SLC25A32	61	Q9H2D1
RAIKLWAKCHNIYSN	PAPOLB	226	Q9NRJ5
ALRCHAWKDKLVYNV	FCGR1BP	121	Q92637
QEHKTAALVCKQWYR	FBXO42	66	Q6P3S6
DFWILSKILKNCLYI	LRRC34	111	Q8IZ02
TIQLYKHLNLKSCVW	FRAS1	3421	Q86XX4
TKNPCWFLKNVYLIH	EYS	441	Q5T1H1
LSLWQKHKYYLISVC	NFXL1	881	Q6ZNB6
CVWSLLKHGVSLYIQ	IBTK	101	Q9P2D0
FYQKVWKVLQKCHGL	PHKA1	1071	P46020
ILLTVLTCYFWKKNQ	ELAPOR1	921	Q6UXG2
KVICLYHVKLLTWEQ	CCDC190	36	Q86UF4
TQKRYLVKFICLSIW	CXCR2	156	P25025
LWKSSDKICRQLIYH	LRRC75B	106	Q2VPJ9
SIKFIHQECLVQWLK	MARCHF6	31	O60337
VINAYTEINKKHCWK	LARP7	506	Q4G0J3
EELYTKKLWHQLTLQ	PSMD13	26	Q9UNM6
KSLIRLVKHWYQNCK	OAS1	206	P00973
LLVALTCYFWKKNQK	ELAPOR2	941	A8MWY0
CVLSKWKNKYVCQLL	WDPCP	116	O95876
WLAFLNKYKLHGILC	BTAF1	1276	O14981
LIVLVLWFKKHCSYQ	CD1C	316	P29017
LVHSKFQWNYVINLC	GCNT7	191	Q6ZNI0
KELQCLQIYWSIHLG	GFRA2	101	O00451
IKHRLQCKNFTWYLN	GALNT3	476	Q14435
IIYCHKLTIILTKWR	FBXL13	81	Q8NEE6
ALRCHAWKDKLVYNV	FCGR1A	121	P12314
SWYIQSLCNHLKKLV	CASP10	456	Q92851
KCLKYILQWQLATLI	HDAC8	286	Q9BY41
TLKEIHFLKWLDIYC	B3GNT7	216	Q8NFL0
IYQLIKAIHWCHKND	CDKL5	116	O76039
KVCDLKWIHRNSLYS	SCAF11	146	Q99590
VLWHQCLLTLVQRYK	BYSL	376	Q13895
IWNVKYNSIHCVANL	UPF2	816	Q9HAU5
NLILLVKHWYHQVCL	OAS3	201	Q9Y6K5
IRLVKHWYQQCTKIS	OAS3	946	Q9Y6K5
DETAKKIQYLIHCQW	TRMT1L	476	Q7Z2T5
ESHKWLLYNCKLNKV	TRMT5	331	Q32P41
NVNKALIYLWHGCKA	SVIL	1916	O95425
HQLLALTLWKEQNYC	GET4	146	Q7L5D6
WKKIQLLYSQHSLYL	SHLD2	36	Q86V20
CDVHIFNWLIKYIKR	SANBR	196	Q6NSI8
RWSCDHKQNITYLLK	OMG	226	P23515
YLKGNIITWNELCHV	ACVR2B	276	Q13705
LWKKIANNCIFIVIH	PIK3CG	211	P48736
KLILIWEAQSCQHLY	RRP9	221	O43818
CTHYVILWQLAKITE	STAG2	736	Q8N3U4
TTYVHKGLLQLQWKQ	TOMM70	511	O94826
LWDHNQCRKILSYKQ	ZNF585A	101	Q6P3V2
WIYSCNEKQKLLPHQ	XRCC1	611	P18887
IWWNLRKTCYQIVKH	SCN11A	1041	Q9UI33
AKELYWTLKQAQLHC	SH2D4B	186	Q5SQS7
YHCWLVSKNKSTLEA	ZDHHC2	231	Q9UIJ5
DQWVCLSFLLKKYHT	TARBP1	891	Q13395
WLYQNLIKHSSLFVK	UBE3C	116	Q15386
DTWAQKLYNTHLNKC	MYO5A	521	Q9Y4I1